Sign in
4

Changes in Ownership

MYRIAD GENETICS INC Filed Acc 0001219036-21-000010

Chief Scientific Officer sold 83,372 shares at an average $31.96 ($2,664,216)

  • Chief Scientific Officer acquired 50,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

LANCHBURY JERRY S · Chief Scientific Officer

Table I: Non-derivative

5 lines
Date Transaction Shares Price Value Owned after D/I
2021-06-25 Exercise or conversion : show line 1 in the form +21,360 $19.47 $415,879 287,282 D
2021-06-25 Sale : show line 2 in the form −21,360 $32.47 $693,559 265,922 D
2021-06-25 Exercise or conversion : show line 3 in the form +28,640 $19.47 $557,621 294,562 D
2021-06-25 Sale : show line 4 in the form −28,640 $31.97 $915,621 265,922 D
2021-06-25 Sale : show line 5 in the form −33,372 $31.61 $1,055,036 232,550 D
Open-market sales · 83,372 sh · avg $31.96 · $2,664,216

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2021-06-25 Exercise or conversion : show line 6 in the form Non-Qualified Stock Option (right to buy) −21,360 47,280 D
2021-06-25 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) −28,640 18,640 D
Loading xslF345X03/edgardoc.xml…